HR 8223 United States House · 118th Congress

Advancing Menopause Care and Mid-Life Women’s Health Act

The Advancing Menopause Care and Mid-Life Women's Health Act (HR 8223) establishes federal research, public health, and training initiatives to improve care for women experiencing perimenopause and menopause. It authorizes $25 million annually for research on menopausal symptoms and related health conditions like osteoporosis, mental health disorders, and chronic pain, plus $10 million each for public health promotion, awareness campaigns, and healthcare provider training programs. The bill creates Centers of Excellence in menopause care, requires a data dashboard tracking health outcomes, and mandates annual reports on barriers to care in underserved areas. It directly affects women experiencing menopause, healthcare providers, and institutions serving mid-life women. The legislation runs from fiscal years 2025 through 2029 with specific funding allocations for each component.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 2, 2024 Last action May 10, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
May 10, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 2, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
May 2, 2024
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors